Pricing Log in Create free account
Saturday 17 October 2026 Export JYNT’s income statement to Excel — free account

The Joint Corp.

JYNT Healthcare Medical Care Facilities

In the quarter to June 2026, revenue grew 14.4%, EPS grew 400.0% and free cash flow grew 432.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

7.03 0.12 +1.74%
Market cap
$97.7M
P/E
26.0×
Fwd P/E
16.9×
Dividend yield
—
F-score
7/9
Altman Z
2.39
Beneish M
−2.27
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 1.98
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy 1 3 2 2 — 1 1 — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 16.81%

Capital & Financial Ratios $m

Market Cap 97.73
Revenue 58.55
Net Income 3.80
Free Cash Flow 4.23
Net Debt (23.00)
Current Ratio 1.83 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 26.04
Fwd P/E 16.90
P/S ratio 1.71
P/B ratio 6.31 (above 6: high)
Past 5Y EPS Growth (26.73%) (below 0%: weak)
This Y EPS Growth 1,300.00% (at or above 15%: strong)
Next Y EPS Growth 63.89% (at or above 15%: strong)
Next Y revenue growth 10.94% (at or above 10%: strong)
Next 5Y EPS Growth 25.00% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.4×, against a ten-year median of 2.7×; over the ten years it ranged from −58.1× in 2024 to 20.6× in 2021.
P/E against its own 10 years 0.34%
10-year low 10-year high
P/S against its own 10 years 6.53%
10-year low 10-year high
P/B against its own 10 years 20.35%
10-year low 10-year high
EV/Sales against its own 10 years 5.96%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 19 26 24 23
Receivables 3 3 3 2
Inventory — — — —
Other — — — —
44 75 52 44
2023 2024 2025 Q'26
Payables 1 2 2 1
ST’ Debt — — — —
Other 3 5 6 4
34 49 33 24

Compound Annual Growth %

10y 5y 3y
Sales 14.78% (1.33%) (18.46%)
Cash Flow 0.00% (30.31%) (39.27%)
Earnings 0.00% (26.07%) 66.78%
Book Value (3.11%) (6.52%) (22.65%)

Revenue $m

Mar Jun Sep Dec Year
’26 15 15 — — —
’25 13 13 13 15 55
’24 12 13 13 15 52
’23 28 29 29 — 47
’22 22 25 26 28 101
’21 18 20 21 21 80
’20 14 13 15 17 59
Fiscal quarters ending in the months shown.
value withheld pending a data check

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (1) 2 — — —
’25 (4) 1 2 3 2
’24 3 (1) 3 4 9
’23 6 1 4 3 15
’22 0 (1) 4 5 8
’21 2 7 3 1 14
’20 1 2 4 4 11
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) 2 — — —
’25 (4) 0 1 3 0
’24 2 (1) 3 4 8
’23 5 0 3 2 10
’22 (1) (6) 0 3 2
’21 0 4 1 0 7
’20 0 1 4 2 7
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.09 0.05 — — —
’25 0.05 0.01 0.06 0.07 0.19
’24 0.06 (0.24) (0.21) (0.18) (0.56)
’23 0.15 (0.02) (0.05) (0.75) (0.65)
’22 0.00 (0.06) 0.05 0.04 0.04
’21 0.16 0.18 0.13 0.04 0.48
’20 0.06 0.01 0.11 0.72 0.90
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.5
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 1.85 2.48 4.67 7.88 7.67 26.28 12.85 7.31 8.88 7.50

Analyst estimates 2026–2028

Powerpack
High 5.89 6.00 9.64 21.80 27.91 111.06 66.42 20.00 17.82 13.47
People
People Employees 94 148 138 150 425 601 781 794 736 330
Revenue/emp, $m 0.22 0.17 0.27 0.32 0.14 0.13 0.13 0.06 0.07 0.17
Income, $m
Income, $m Revenue 21 25 37 48 59 80 101 47 52 55
Gross margin, % 85.68 87.06 88.24 88.51 88.91 90.42 90.94 77.69 77.92 79.55
EBT (15) (3) 0 3 5 6 1 0 (2) 0
EBT margin, % (73.13) (13.63) 0.30 6.96 9.22 7.57 0.69 0.54 (3.08) (0.42)
Net income (15) (3) 0 3 13 8 1 (10) (6) 3
Depreciation 3 2 2 2 3 4 7 9 5 2
Per share, $
Per share, $ Revenue 1.62 1.88 2.68 3.51 4.19 5.59 6.99 3.20 3.50 3.63
Earnings (1.20) (0.25) 0.01 0.24 0.94 0.50 0.04 (0.66) (0.57) 0.19
Cash flow (0.85) (0.01) 0.40 0.54 0.80 0.97 0.57 1.00 0.63 0.12
Capex (0.15) (0.03) (0.08) (0.30) (0.30) (0.49) (0.41) (0.34) (0.08) (0.10)
Free cash flow (1.00) (0.04) 0.32 0.24 0.50 0.48 0.16 0.66 0.55 0.02
Book value 0.55 0.09 0.05 0.41 1.51 2.12 2.25 1.69 1.39 1.00
Shares, m 13 13 14 14 14 14 14 15 15 15
Valuation, ×
Valuation, × P/E 0.00 0.00 770.37 70.17 28.24 125.70 451.48 0.00 0.00 45.89
P/S 1.64 2.60 3.10 4.60 6.27 11.76 1.97 2.95 3.04 2.40
P/B 4.86 56.27 156.30 38.99 17.41 31.04 6.12 5.60 7.67 8.75
EV/Sales 1.48 2.47 2.89 4.47 5.99 11.56 1.91 2.63 2.58 2.00
EV/FCF (2.39) (72.59) 26.38 90.43 62.54 169.20 (65.11) 28.07 45.56 (22.20)
Cash, $m
Cash, $m Operating cash flow (11) 0 5 8 11 14 8 15 9 2
Capex (2) 0 (1) (4) (4) (7) (6) (5) (1) (2)
Free cash flow (13) (1) 4 3 7 7 2 10 8 0
Balance, $m
Balance, $m Working capital 0 1 1 0 7 5 (6) 11 26 19
Total debt 0 1 1 2 5 2 2 2 — —
Net debt (3) (3) (8) (6) (16) (18) (8) (17) (26) (24)
Shareholders’ equity 7 1 1 6 21 30 33 25 21 15
Returns, %
Returns, % ROA (60.19) (19.34) 0.70 9.90 24.03 9.89 0.69 (10.79) (6.81) 4.03
ROIC (239.74) 0.00 0.00 0.00 66.43 30.67 2.15 2.63 0.00 0.00
ROE (109.94) (84.97) 15.60 103.09 98.09 29.42 1.99 (34.00) (25.51) 16.26
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

The Joint Corp. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
AUNA Auna S.A. $392.3M 76.0× 5.2× +20.51% (above 0%: growing) −61.29% (below 0%: shrinking) +121.08% (above 0%: growing) 35.72% 13.09% Compare
SRTA Strata Critical Medical, Inc. $384.0M 9.0× — (loss-making) +60.74% (above 0%: growing) n/m +150.33% (above 0%: growing) 20.98% (7.46%) Compare
AIRS AirSculpt Technologies, Inc. $102.0M — (loss-making) — (loss-making) −2.53% (below 0%: shrinking) n/m −131.07% (below 0%: shrinking) 61.38% (0.07%) Compare
JYNT The Joint Corp. $97.7M 26.0× 16.9× +14.41% (above 0%: growing) +400.00% (above 0%: growing) +432.31% (above 0%: growing) 83.68% (2.43%)
PARK Park Dental Partners, Inc. $91.3M — (loss-making) — +12.15% (above 0%: growing) −65.84% (below 0%: shrinking) −34.78% (below 0%: shrinking) 14.37% 1.90% Compare
BTMD biote Corp. $39.9M 6.8× 11.0× −9.48% (below 0%: shrinking) n/m −174.16% (below 0%: shrinking) 65.38% (7.93%) Compare
PIII P3 Health Partners Inc. $30.1M — (loss-making) — +8.60% (above 0%: growing) n/m −272.24% (below 0%: shrinking) 22.26% 10.67% Compare
CCEL Cryo-Cell International Inc. $29.4M — (loss-making) 43.8× −0.02% (below 0%: shrinking) +77.78% (above 0%: growing) −58.37% (below 0%: shrinking) 79.38% 28.04% Compare
DCGO DocGo Inc. $27.9M — (loss-making) — (loss-making) −8.70% (below 0%: shrinking) n/m −132.28% (below 0%: shrinking) 30.52% (24.41%) Compare
Median of peers $65.6M 9.0× 11.0× +4.29% −61.29% −94.72% 33.12% 0.92%

All 55 Medical Care Facilities stocks →

The Joint Corp. (JYNT) key facts

  • The Joint Corp. (JYNT) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, JYNT traded at $7.03, a market capitalization of $97.7 million.
  • Return on equity was 16.3% and debt-to-equity 0.00.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 2.39 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

The Joint Corp. (JYNT) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/JYNT · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com